Management of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting
AFCAS
1 other identifier
observational
996
1 country
1
Brief Summary
Treatment of patients suffering from atrial fibrillation pose problems when percutaneous coronary intervention with stent implantation (PCI-S) is performed. In the absence of solid evidence-based data, no definite recommendations for the management of this patient subset are currently given in the guidelines on percutaneous coronary intervention issued by the most prominent Cardiology Associations. The management of the antithrombotic treatment before invasive cardiac procedures is also incompletely defined. In this study we aim to determine in patients with atrial fibrillation undergoing PCI-S:
- 1.the contemporary antithrombotic management;
- 2.the relative safety and efficacy of the various post-PCI antithrombotic regimens;
- 3.the safety and efficacy of drug-eluting stents (DES), bare-metal stents (BMS), and bioactive stents (BAS);
- 4.the safety of various periprocedural antithrombotic strategies including glycoprotein IIb/IIIa inhibitors and bivalirudin;
- 5.safety and efficacy of radial vs femoral approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 8, 2008
CompletedFirst Posted
Study publicly available on registry
January 17, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedJune 30, 2010
December 1, 2007
January 8, 2008
June 29, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
major hemorrhagic and thrombotic/thromboembolic complications including cardiac death
one year
Study Arms (1)
1
Patient with atrial fibrillation who underwent PCI
Interventions
Eligibility Criteria
Patients with atrial fibrillation undergoing PCI-S.
You may qualify if:
- Patients with atrial fibrillation who undergo PCI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Juhani Airaksinen
Turku, 20520, Finland
Related Publications (3)
Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GY, Airaksinen JK. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ Open. 2014 May 13;4(5):e004700. doi: 10.1136/bmjopen-2013-004700.
PMID: 24823675DERIVEDRubboli A, Schlitt A, Kiviniemi T, Biancari F, Karjalainen PP, Valencia J, Laine M, Kirchhof P, Niemela M, Vikman S, Lip GY, Airaksinen KE; AFCAS Study Group. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clin Cardiol. 2014 Jun;37(6):357-64. doi: 10.1002/clc.22254. Epub 2014 Jan 30.
PMID: 24481953DERIVEDSchlitt A, Rubboli A, Lip GY, Lahtela H, Valencia J, Karjalainen PP, Weber M, Laine M, Kirchhof P, Niemela M, Vikman S, Buerke M, Airaksinen KE; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study. Catheter Cardiovasc Interv. 2013 Dec 1;82(7):E864-70. doi: 10.1002/ccd.25064. Epub 2013 Aug 28.
PMID: 23765437DERIVED
Biospecimen
Anticoagulation samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juhani KE Airaksinen, Professor
University of Turku
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 8, 2008
First Posted
January 17, 2008
Study Start
January 1, 2007
Study Completion
February 1, 2010
Last Updated
June 30, 2010
Record last verified: 2007-12